Phreesia, Inc. (NYSE:PHR – Get Free Report) SVP David Linetsky sold 1,716 shares of the business’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $23.25, for a total transaction of $39,897.00. Following the transaction, the senior vice president now owns 203,318 shares of the company’s stock, valued at approximately $4,727,143.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
David Linetsky also recently made the following trade(s):
- On Tuesday, July 16th, David Linetsky sold 1,820 shares of Phreesia stock. The shares were sold at an average price of $23.74, for a total transaction of $43,206.80.
- On Thursday, June 20th, David Linetsky sold 66 shares of Phreesia stock. The shares were sold at an average price of $19.73, for a total transaction of $1,302.18.
- On Tuesday, June 18th, David Linetsky sold 41 shares of Phreesia stock. The shares were sold at an average price of $19.20, for a total transaction of $787.20.
Phreesia Trading Up 3.9 %
Shares of Phreesia stock opened at $24.68 on Friday. Phreesia, Inc. has a 12-month low of $12.05 and a 12-month high of $29.16. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.03. The stock has a market cap of $1.42 billion, a PE ratio of -11.37 and a beta of 0.93. The company has a 50-day moving average of $23.72 and a two-hundred day moving average of $22.75.
Analyst Ratings Changes
Get Our Latest Stock Analysis on Phreesia
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in the stock. Ensign Peak Advisors Inc increased its holdings in Phreesia by 3.2% in the second quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock valued at $477,000 after buying an additional 700 shares in the last quarter. Conestoga Capital Advisors LLC grew its position in shares of Phreesia by 1.0% in the first quarter. Conestoga Capital Advisors LLC now owns 78,085 shares of the company’s stock valued at $1,869,000 after purchasing an additional 750 shares during the last quarter. ProShare Advisors LLC grew its position in shares of Phreesia by 8.6% in the first quarter. ProShare Advisors LLC now owns 9,522 shares of the company’s stock valued at $228,000 after purchasing an additional 751 shares during the last quarter. Rhumbline Advisers grew its position in shares of Phreesia by 1.0% in the second quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock valued at $1,741,000 after purchasing an additional 853 shares during the last quarter. Finally, Swiss National Bank grew its position in shares of Phreesia by 1.0% in the first quarter. Swiss National Bank now owns 104,300 shares of the company’s stock valued at $2,496,000 after purchasing an additional 1,000 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.
About Phreesia
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Recommended Stories
- Five stocks we like better than Phreesia
- Want to Profit on the Downtrend? Downtrends, Explained.
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- What Does a Stock Split Mean?
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- What Investors Need to Know About Upcoming IPOs
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.